Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07830732 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A

Study acronym: FRONTIERAHA
StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Novo Nordisk
268 trials monitored
See 15 trials at risk
Hemophilia
241 trials monitored
See 12 trials at risk
The purpose of this study is to find out if denecimig is safe and effective for treating people who have acquired haemophilia A. Participants will be in this study for up to around 1 year and 5 months (73 week).
Trial Details
NCT Number NCT07830732
Lead Sponsor Novo Nordisk A/S
Conditions
(from sponsor)		 Haemophilia A
Related terms Hemophilia A
Enrollment 84 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov